3-amino-pyridines as gpbar1 agonists

作者: Christoph Ullmer , Hans Richter , Henrietta Dehmlow , Patrizio Mattei , Sherrie Lynn Pietranico-Cole

DOI:

关键词:

摘要: This invention relates to novel 3-aminopyridines of the formula (I) wherein B1, B2 and R1 R6 are as defined in description claims, well pharmaceutically acceptable salts thereof. These compounds GPBAR1 agonists can be used medicaments for treatment diseases such type II diabetes.

参考文章(24)
Yasunori Moritani, Akira Oku, Yasunori Tsuboi, Shigeru Furukubo, Naomitsu Hirano, Chieko Okagaki, Pyrrolidine derivatives as cb1-receptor antagonists ,(2005)
Andreas Koblet, Jens-Uwe Peters, Patrick Schnider, Andrew Sleight, Heinz Stadler, Torsten Hoffmann, Dual nk1/nk3 antagonists for treating schizophrenia ,(2004)
Timothy J. Guzi, Praveen K. Tadikonda, Tzu Tshin Wong, Lianyun Zhao, Panduranga Adulla P. Reddy, Luis E. Torres, M. Arshad Siddiqui, David F. Cauble, Shuyi Tang, Heterocyclic amide compounds as protein kinase inhibitors ,(2008)
Tanya Michelle Jewell, John Howard Tatlock, Angelica Linton, Hui Li, Javier Gonzalez, Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same ,(2005)
Niko Schmiedeberg, Klemens Högenauer, Herbert Jaksche, Luca Arista, Gudrun Werner, Amide derivatives and their application for the treatment of g protein related diseases ,(2007)